Volf I - Search Results

1

Estimation of platelet function under high shear conditions to assist a rapid diagnosis of Heyde Syndrome.

Schmid W, Steindl-Munda P, Madl C, Budde U, Volf I, Panzer S. Schmid W, et al. Among authors: volf i. Platelets. 2008 Dec;19(8):636-40. doi: 10.1080/09537100802334426. Platelets. 2008. PMID: 19012181

2

CD36-fibrin interaction propagates FXI-dependent thrombin generation of human platelets.

Döhrmann M, Makhoul S, Gross K, Krause M, Pillitteri D, von Auer C, Walter U, Lutz J, Volf I, Kehrel BE, Jurk K. Döhrmann M, et al. Among authors: volf i. FASEB J. 2020 Jul;34(7):9337-9357. doi: 10.1096/fj.201903189R. Epub 2020 May 28. FASEB J. 2020. PMID: 32463151

3

The influence of VIP and epoprostenol on platelet CD62P expression and primary haemostasis in vitro.

Zwerina J, Landsteiner H, Leitgeb U, Volf I, Petkov V, Zimpfer M, Blaicher A. Zwerina J, et al. Among authors: volf i. Platelets. 2004 Feb;15(1):55-60. doi: 10.1080/0953710032000159294. Platelets. 2004. PMID: 14985177

4

Oxidation by hypochlorite converts protective HDL into a potent platelet agonist.

Assinger A, Schmid W, Eder S, Schmid D, Koller E, Volf I. Assinger A, et al. Among authors: volf i. FEBS Lett. 2008 Mar 5;582(5):778-84. doi: 10.1016/j.febslet.2008.02.001. Epub 2008 Feb 11. FEBS Lett. 2008. PMID: 18267121 Free article.

5

Platelet-stimulating effects of oxidized LDL are not attributable to toxic properties of the lipoproteins.

Schmid W, Assinger A, Lee A, Bielek E, Koller E, Volf I. Schmid W, et al. Among authors: volf i. Thromb Res. 2008;122(5):630-9. doi: 10.1016/j.thromres.2008.01.015. Epub 2008 Apr 3. Thromb Res. 2008. PMID: 18387657

6

Specific binding of hypochlorite-oxidized HDL to platelet CD36 triggers proinflammatory and procoagulant effects.

Assinger A, Koller F, Schmid W, Zellner M, Babeluk R, Koller E, Volf I. Assinger A, et al. Among authors: volf i. Atherosclerosis. 2010 Sep;212(1):153-60. doi: 10.1016/j.atherosclerosis.2010.05.010. Epub 2010 May 13. Atherosclerosis. 2010. PMID: 20684828

7

Decreased VASP phosphorylation in platelets of male and female smokers of young age.

Assinger A, Schmid W, Volf I. Assinger A, et al. Among authors: volf i. Platelets. 2010;21(8):596-603. doi: 10.3109/09537104.2010.505674. Epub 2010 Sep 7. Platelets. 2010. PMID: 20822337

8

Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.

Hoetzenecker K, Assinger A, Lichtenauer M, Mildner M, Schweiger T, Starlinger P, Jakab A, Berényi E, Pavo N, Zimmermann M, Gabriel C, Plass C, Gyöngyösi M, Volf I, Ankersmit HJ. Hoetzenecker K, et al. Among authors: volf i. Basic Res Cardiol. 2012 Sep;107(5):292. doi: 10.1007/s00395-012-0292-2. Epub 2012 Aug 17. Basic Res Cardiol. 2012. PMID: 22899170 Free PMC article.

9

Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.

Kulnigg-Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldhör T, Evstatiev R, Kamali H, Volf I, Gasche C. Kulnigg-Dabsch S, et al. Among authors: volf i. Inflamm Bowel Dis. 2013 Jul;19(8):1609-16. doi: 10.1097/MIB.0b013e318281f4db. Inflamm Bowel Dis. 2013. PMID: 23644823 Clinical Trial.

10

Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).

Badrnya S, Assinger A, Volf I. Badrnya S, et al. Among authors: volf i. Int J Mol Sci. 2013 May 10;14(5):10107-21. doi: 10.3390/ijms140510107. Int J Mol Sci. 2013. PMID: 23665908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results